UWA launches powerful DNA sequencer

Thursday, 23 February, 2012

Researchers at the University of Western Australia (UWA) have launched the Hi-Seq Illumina Deep Sequencer, the most powerful platform worldwide for next-generation sequencing.

In a single day of use, at the cost of a few thousand dollars, this technology will allow researchers to obtain the sequence equivalent of the entire human genome project. A decade ago, this took $4 billion and 10 years to complete.

To put that in perspective, it would take a person typing 60 words per minute, eight hours a day, some 50 years to type the three billion letters, or base pairs, that make up the human genome.

Deep sequencers provide powerful information by reading every base pair of DNA that makes up an organism, and sorting this data into meaningful genetic maps. Using this information, researchers are making incredible breakthroughs as they discover the genes responsible for diseases in plants and animals, find new species and map our evolutionary past.

“A genome sequence is the ultimate genetic map,” says Professor Jim Whelan.

“The availability of this technology opens up the sequencing field to ecologists, evolutionary biologists, environmental scientists and a variety of cellular and genetic disciplines.

“We are no longer tied to just studying model species such as mice or the model plant Arabidopsis thaliana. It develops our potential to cheaply sequence individuals in a population, varieties, mutants or clones in a variety of organisms, and study how they respond to the environment under WA conditions.

“This will greatly increase our ability to fight disease and to breed a variety of crop species for desired traits, such as increased drought, heat, pest or salinity tolerance, thus allowing producers to respond to environmental change or disease in a rapid manner.”

Related News

Blood-based biomarker can detect sleep deprivation

The biomarker detected whether individuals had been awake for 24 hours with a 99.2% probability...

Epigenetic signature helps to diagnose rare breast tumour

The current way of diagnosing phyllodes tumours is to analyse their cellular features under a...

New instrument measures cardiovascular disease biomarkers

CVD-21 enables a 'liquid cardiovascular biopsy' for quantification of multiple...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd